1-Year Outcomes with COMBO Stents in Small-Vessel Coronary Disease: Subgroup Analysis From the COMBO Collaboration
- 7 May 2020
- journal article
- research article
- Published by Elsevier BV in Cardiovascular Revascularization Medicine
- Vol. 21 (12), 1542-1547
- https://doi.org/10.1016/j.carrev.2020.05.002
Abstract
No abstract availableKeywords
Funding Information
- OrbusNeich Medical BV
- OrbusNeich Medical
This publication has 28 references indexed in Scilit:
- Understanding and managing in-stent restenosis: a review of clinical data, from pathogenesis to treatmentJournal of Thoracic Disease, 2016
- Drug-Eluting or Bare-Metal Stents for Coronary Artery DiseaseThe New England Journal of Medicine, 2016
- Percutaneous Coronary Interventions for the Treatment of Stenoses in Small Coronary ArteriesJACC: Cardiovascular Interventions, 2016
- 1-Year Results of the REMEDEE RegistryJACC: Cardiovascular Interventions, 2016
- Small-vessel treatment with contemporary newer-generation drug-eluting coronary stents in all-comers: Insights from 2-year DUTCH PEERS (TWENTE II) randomized trialAmerican Heart Journal, 2016
- Third Universal Definition of Myocardial InfarctionJournal of the American College of Cardiology, 2012
- Long-Term Clinical Outcome After Fractional Flow Reserve–Guided Percutaneous Coronary Revascularization in Patients With Small-Vessel DiseaseCirculation: Cardiovascular Interventions, 2012
- Development of a Novel Prohealing Stent Designed to Deliver Sirolimus From a Biodegradable Abluminal MatrixCirculation: Cardiovascular Interventions, 2010
- Anti-CD34 Antibodies Immobilized on the Surface of Sirolimus-Eluting Stents Enhance Stent EndothelializationJACC: Cardiovascular Interventions, 2010
- Clinical End Points in Coronary Stent TrialsCirculation, 2007